Raymond James Starts Adaptimmune Therapeutics plc (ADAP) at Outperform
Tweet
Share
E-mailGet Alerts ADAP Hot Sheet
Price: $1.08 +6.93%
Rating Summary:
8 Buy, 2 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 10 | New: 13
Rating Summary:
8 Buy, 2 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 10 | New: 13
Join SI Premium – FREE
Raymond James initiated coverage on Adaptimmune Therapeutics plc (NASDAQ: ADAP) with an Outperform rating and a price target of $16.00.
For an analyst ratings summary and ratings history on Adaptimmune Therapeutics plc click here. For more ratings news on Adaptimmune Therapeutics plc click here.
Shares of Adaptimmune Therapeutics plc closed at $7.30 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lake Street Capital Markets Starts Research Solutions Inc. (RSSS) at Buy
- UBS Starts Hutchmed China Ltd (13:HK) at Buy
- Northland Starts Life Time Group Holdings Inc (LTH) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
